[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100603259":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":29,"locations":37,"responsibleParty":74,"collaborators":20,"id":76,"slug":20,"hasResults":77,"nctId":78,"briefTitle":79,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":77,"sex":82,"minAge":83,"maxAge":20,"enrollmentInfo":84,"targetDuration":20,"studyType":87,"phases":88,"briefSummary":90,"conditions":91,"keywords":94,"overallStatus":40,"whyStopped":20,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":110},{"fullName":5,"class":6},"University of Aarhus","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Fluorescence-guided surgery cohort","EXPERIMENTAL","Patients with intermediate-to-high grade sarcomas eligible for curative surgical treatment at time of surgery. Surgery will be augmented by guidance through the use of a near-infrared camera and fluorescent dye administered hours prior to surgery.",[13],"Procedure: Fluorescent-guided Surgery",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"PROCEDURE","Fluorescent-guided Surgery","Surgical treatment of the patient group will include the administration of a fluorescent dye and intraoperatively the resection will be aided and guided by the fluorescent signal. The wound bed will be inspected, areas with fluorescent signal will be excised and obtained separately for histopathology. Patients will receive the current post-operative standard of care for sarcoma patients",[9],null,[22,26],{"name":23,"affiliation":24,"role":25},"Thomas Baad-Hansen, MD, PhD","Orthopedic Surgical Department, Aarhus University Hospital","PRINCIPAL_INVESTIGATOR",{"name":27,"affiliation":24,"role":28},"Christian Kveller, MD","STUDY_DIRECTOR",[30,34],{"name":27,"role":31,"phone":32,"phoneExt":20,"email":33},"CONTACT","+45 51 48 13 19","chrkve@rm.dk",{"name":23,"role":31,"phone":35,"phoneExt":20,"email":36},"+45 28603490","thombaad@rm.dk",[38,57],{"facility":39,"status":40,"city":41,"state":20,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Aarhus University Hospital","RECRUITING","Aarhus N","8200","Denmark","DK",{"type":46,"coordinates":47},"Point",[48,49],10.17317,56.20367,{"lat":49,"lon":48},[52,53,54,56],{"name":27,"role":31,"phone":32,"phoneExt":20,"email":33},{"name":23,"role":31,"phone":35,"phoneExt":20,"email":36},{"name":27,"role":55,"phone":20,"phoneExt":20,"email":20},"SUB_INVESTIGATOR",{"name":23,"role":25,"phone":20,"phoneExt":20,"email":20},{"facility":58,"status":40,"city":59,"state":20,"zip":60,"country":43,"countryCode":44,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"Rigshospitalet","Copenhagen","2100",{"type":46,"coordinates":62},[63,64],12.56553,55.67594,{"lat":64,"lon":63},[67,71,72],{"name":68,"role":31,"phone":69,"phoneExt":20,"email":70},"Michael M Petersen, MD, PhD","+45 3545 8900","Michael.Moerk.Petersen@regionh.dk",{"name":68,"role":25,"phone":20,"phoneExt":20,"email":20},{"name":73,"role":55,"phone":20,"phoneExt":20,"email":20},"Christina E Holm, MD, PhD",{"type":75,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100603259",false,"NCT07134192","Fluorescence-Guided Optimization of Sarcoma Margins","FOCUS","Inclusion Criteria:\n\n* Biopsy verified intermediate-to-high grade sarcoma of theextremity or trunk wall\n* Age\\>18 years old\n* Tumor operable\n* Curative intent at time of surgery\n* Consent of patient\n\nExclusion Criteria:\n\n* History of allergic reaction to iodine-containing pharmaceuticals\n* End-stage renal disease or eGFR \\\u003C15\n* Patient decision\n* Lack of capacity\n* Inoperability","ALL","18 Years",{"count":85,"type":86},90,"ESTIMATED","INTERVENTIONAL",[89],"NA","This is a Danish national multicenter prospective cohort study to evaluate if fluorescence-guided surgery (FGS) using indocyanine green (ICG) can reduce the rate of positive margins following sarcoma resection.",[92,93],"Soft Tissue Sarcoma of the Trunk and Extremities","Sarcoma",[93,95,96,97,98,99,100],"ICG","Indocyanine green","Fluorescence Guided Surgery","FGS","STS","Soft Tissue Sarcoma","2026-06-29",{"date":103,"type":104},"2026-07-01","ACTUAL",{"date":106,"type":104},"2025-09-01",{"date":108,"type":86},"2028-03-01",{"name":5,"class":6},2]